HomeCompareHALN vs ABBV

HALN vs ABBV: Dividend Comparison 2026

HALN yields 2000000.00% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HALN wins by $4.879226400974806e+39M in total portfolio value
10 years
HALN
HALN
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full HALN calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — HALN vs ABBV

📍 HALN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHALNABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HALN + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
HALN pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HALN
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, HALN beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HALN + ABBV for your $10,000?

HALN: 50%ABBV: 50%
100% ABBV50/50100% HALN
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

HALN
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HALN buys
0
ABBV buys
0
No recent congressional trades found for HALN or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHALNABBV
Forward yield2000000.00%3.67%
Annual dividend / share$2.00$6.20
Payout ratio50%58%
1-year div growth0%4.7%
5-year div CAGR0%8.9%
Portfolio after 10y$4.879226400974806e+39M$39.9K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$1,154.43
Total dividends collected$4.879195005460081e+39M$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HALN vs ABBV ($10,000, DRIP)

YearHALN PortfolioHALN Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,520$399.75+$200.00MHALN
2$3,738,731,768,458$3,738,517,757,009.35$13,261$450.98+$3738731.76MHALN
3$65,315,062,866,930,490$65,311,062,423,938,240.00$15,255$508.41+$65315062866.92MHALN
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$17,536$572.74+$1066400830062625.00MHALN
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$20,145$644.78+$16272182796453826560.00MHALN
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$23,126$725.38+$2.3205424011366188e+23MHALN
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$26,532$815.52+$3.0927990661046884e+27MHALN
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$30,420$916.26+$3.8524105697352695e+31MHALN
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$34,855$1,028.80+$4.484688260147987e+35MHALN
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$39,914$1,154.43+$4.879226400974806e+39MHALN

HALN vs ABBV: Complete Analysis 2026

HALNStock

Halo Companies, Inc., through its subsidiaries, operates as a distressed asset services company in the United States. It offers technology-driven asset management, portfolio due diligence, acquisition, repositioning, and liquidation strategies for the private investment and mortgage servicing industry. The company focuses its distressed asset services, portfolio due diligence, and asset liquidation strategies on single family residential real estate for its business customers, primarily distressed debt investors or debt servicers to market turnkey solutions for improved performance and monetization of their portfolios. It also provides asset management and mortgage services to investors and asset owners, including buying and managing distressed real estate owned and non-performing loans. The company was founded in 2004 and is headquartered in Plano, Texas.

Full HALN Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this HALN vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HALN vs SCHDHALN vs JEPIHALN vs OHALN vs KOHALN vs MAINHALN vs JNJHALN vs MRKHALN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.